Natacha Caizergues

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
This prospective, multicentre, observational study assessed usability and utility (co-primary endpoints) of the consistency in r-hFSH starting doses for individualized treatment (CONSORT) calculator in French routine clinical practice. Physicians first planned their recombinant human follicle-stimulating hormone (r-hFSH) starting dose. The CONSORT(More)
  • 1